Insights

Strategic funding Leverage Click Therapeutics’ substantial funding and recent Series D investment from Boehringer Ingelheim to position joint commercialization opportunities for CT-155 and other PDTx offerings with co-investment and strategic partnerships.

Expansion potential Target enterprise pharma and health systems given ongoing expansions in platform technologies and FDA-regulated prescription digital therapeutics across psychiatry, neurology, oncology, cardiology and immunology to broaden clinical indications.

Commercial momentum Capitalize on new product launches and collaborations, such as Migraine PowerPlug with Ultrahuman and AI-driven platform enhancements, to offer cross-sell of digital therapeutics alongside wearables, data analytics, and remote patient monitoring solutions.

Executive transitions Monitor leadership and board movements, including appointments and departures, to identify timing for strategic discussions, alliance opportunities, and renewal of existing contracts or joint development discussions.

Regulatory strength Position Click’s FDA-regulated, HIPAA-compliant digital therapeutics as low-risk, scalable digital health assets for payer conversations, potential reimbursement pathways, and clinical trial integrations with partners seeking proven, data-driven outcomes.

Similar companies to Click Therapeutics, Inc.

Click Therapeutics, Inc. Tech Stack

Click Therapeutics, Inc. uses 8 technology products and services including UserWay, Databricks, Power BI, and more. Explore Click Therapeutics, Inc.'s tech stack below.

Media & News

Click Therapeutics, Inc.'s Email Address Formats

Click Therapeutics, Inc. uses at least 4 email formats:
Click Therapeutics, Inc. Email FormatsExamplePercentage
FLast@clicktherapeutics.comJDoe@clicktherapeutics.com
70%
First@clicktherapeutics.comJohn@clicktherapeutics.com
17%
First.Last@clicktherapeutics.comJohn.Doe@clicktherapeutics.com
9%
Last@clicktherapeutics.comDoe@clicktherapeutics.com
4%

Frequently Asked Questions

What is Click Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Click Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Click Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Click Therapeutics, Inc.'s official website is clicktherapeutics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Click Therapeutics, Inc. generate?

Minus sign iconPlus sign icon
As of October 2026, Click Therapeutics, Inc.'s annual revenue is estimated to be $25M - $50M.

What is Click Therapeutics, Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
Click Therapeutics, Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Click Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of October 2026, Click Therapeutics, Inc. has approximately 104 employees across 4 continents, including North America, Europe and Africa. Key team members include Chief Executive Officer: G. T., Chief Of Staff: J. B. and Digital Marketing Director: B. E. Explore Click Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Click Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Click Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Click Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Click Therapeutics, Inc.'s tech stack includes UserWay, Databricks, Power BI, Apache Airflow, CircleCI, Zendesk, ServiceNow and Cisco Meraki.

What is Click Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Click Therapeutics, Inc.'s email format typically follows the pattern of FLast@clicktherapeutics.com. Find more Click Therapeutics, Inc. email formats with LeadIQ.

How much funding has Click Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of October 2026, Click Therapeutics, Inc. has raised $1.1B in funding. The last funding round occurred on Apr 09, 2026 for $49M.

When was Click Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Click Therapeutics, Inc. was founded in 2012.
Click Therapeutics, Inc. logo

Click Therapeutics, Inc.

Biotechnology ResearchNew York, United States51-200 Employees

Click Therapeutics, Inc. operates in biotechnology research and develops software as prescription medical treatments, known as prescription digital therapeutics. The company delivers FDA-regulated prescription treatments via smartphone platforms. It positions itself as a leading innovator in Digital Therapeutics, applying technical and scientific rigor alongside patient-centric design to pursue clinically meaningful outcomes. Its platform technologies are expanding to include cognitive, behavioral, and neuromodulatory mechanisms and are supported by data-driven tools such as artificial intelligence and machine learning. Headquartered at 80 White Street, New York, NY 10013, the company has 51 to 200 employees and pursues digital therapeutics across psychiatry, neurology, oncology, cardiology, and immunology.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2012
Employees
51-200

Section iconFunding & Financials

  • $1.1B

    Click Therapeutics, Inc. has raised a total of $1.1B of funding over 16 rounds. Their latest funding round was raised on Apr 09, 2026 in the amount of $49M as a Series D.

  • $25M - $50M

    Click Therapeutics, Inc.'s revenue is estimated to be in the range of $25M - $50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.